DCVC Announcements
Shennon has built an ultra-high-throughput profiling engine that allows it to analyze millions of immune cells on the single-cell level, searching for rare receptors and other targets that will help the company create more effective immunotherapies for solid tumors.
Advancing precision bispecific antibody-drug conjugates to treat cancer
Transforming the treatment of anxiety and other neuropsychiatric disorders
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
Programming stem cells to differentiate into desired cell types, faster